title: Exenatide alters absorption of hydrocortisone in a diabetic patient with panhypopituitarism: iatrogenic adrenal insufficiency.
authors.forename: Yukari
authors.initials: Y
authors.lastname: Fujita
authors.forename: Tetsuhiro
authors.initials: T
authors.lastname: Kitamura
authors.forename: Michio
authors.initials: M
authors.lastname: Otsuki
authors.forename: Daisuke
authors.initials: D
authors.lastname: Tamada
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Tabuchi
authors.forename: Junji
authors.initials: J
authors.lastname: Kozawa
authors.forename: Tetsuyuki
authors.initials: T
authors.lastname: Yasuda
authors.forename: Kohei
authors.initials: K
authors.lastname: Okita
authors.forename: Akihisa
authors.initials: A
authors.lastname: Imagawa
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kaneto
authors.forename: Tohru
authors.initials: T
authors.lastname: Funahashi
authors.forename: Iichiro
authors.initials: I
authors.lastname: Shimomura
mesh_terms: D000309:Adrenal Insufficiency / Q000188:drug therapy*; D003920:Diabetes Mellitus; D004347:Drug Interactions; D000077270:Exenatide; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007018:Hypopituitarism / Q000188:drug therapy*; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D014688:Venoms / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D010455:Peptides; D014688:Venoms; D000077270:Exenatide; D006854:Hydrocortisone